Mexico - Delayed Quote MXN

Genomma Lab Internacional, S.A.B. de C.V. (LABB.MX)

14.59 -0.49 (-3.25%)
At close: 1:59 PM CST

Key Executives

Amounts are as of -- and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in MXN.
NameTitlePayExercisedYear Born
Mr. Juan Marco Sparvieri Chief Executive Officer -- -- --
Engineer Antonio Zamora Galland Executive VP of Finance & Administration and CFO -- -- --
Daniel Suarez Neria Head of Investor Relations -- -- --
Mr. Alejandro Bastón Patiño Executive Vice President of Institutional Relations, Media, Human Resources & Sustainability -- -- --

Genomma Lab Internacional, S.A.B. de C.V.

Av. Antonio Dovalí Jaime, number 70
tower C, floor 2 office "A". Colonia Santa Fe. Alvaro Obregón Mayor's Office
Mexico City, DF 01210
Mexico
52 55 5081 0000 https://www.genommalab.com
Sector: 
Healthcare

Description

Genomma Lab Internacional, S.A.B. de C.V., together with its subsidiaries, provides pharmaceutical and personal care products primarily in Latin America. It develops, sells, and markets a range of branded products in the categories of anti-acne products, self-diagnosis, antibacterial, cream to improve the texture of scarred skin, shampoos, dandruff shampoos, soaps, razors, products to prevent hair loss, ointment for muscle pain, anti-fungal treatments for the relief of colitis, products to counter stress levels, anti-wrinkles, antacids, anti-ulcers, anti-flu, protection and sexual improvement, treatments against hemorrhoids, against varicose veins, osteoarthritis, ophthalmic medications, and infant nutrition. The company was incorporated in 1996 and is based in Mexico City, Mexico.

Corporate Governance

Genomma Lab Internacional, S.A.B. de C.V.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

  • Mar 22, 2024
    Ex-Dividend Date

Upcoming Events

Apr 24, 2024
Genomma Lab Internacional, S.A.B. de C.V. Earnings Call

Related Tickers